| Literature DB >> 33160357 |
Adeola Y Olukosi1, Abiodun Olakiigbe2, Olusola Ajibaye2, Bassey A Orok2, Olugbenga O Aina2, Samuel K Akindele2, Olajumoke O Akinyele2,3,4, Adebayo T Onajole3, Samson T Awolola2, Tolulope Arowolo2,3,4, Bamigboye M Afolabi4.
Abstract
BACKGROUND: Incidence of malaria and anaemia are of public health importance especially in pregnant women in endemic regions, due to the negative health consequences to the mother and fetus. This study aimed to assess the pattern of falciparum malaria infection and anaemia, based on malaria prevention methods practiced by participants.Entities:
Keywords: Anaemia; Behavioural factors; Malaria; Pregnancy; Southwest Nigeria
Mesh:
Substances:
Year: 2020 PMID: 33160357 PMCID: PMC7648425 DOI: 10.1186/s12936-020-03462-8
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Distribution of social and clinical profile of infected and non-infected pregnant women participants attending Ikordu and Ijede General Hospital, Lagos State
| Variable | Item | Freq. (%) | Mean (±sd) of age | Infected | Not infected | χ² | P-value | OR | 95% CI | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Freq. | % | Freq. | % | ||||||||
| Age | All | 113 (100.0) | 30.0 (4.7) | 22 | 19.5 | 91 | 80.5 | - | - | - | - |
| ≤ 20 | 4 (3.6) | 18.5 (3.0) | 1 | 25.0 | 3 | 3.3 | 0.00 | 1.00 | 1.40 | 0.14, 14.11 | |
| 21.25 | 24 (21.2) | 23.8 (1.2) | 6 | 25.0 | 18 | 19.8 | 0.59 | 0.44 | 1.52 | 0.52, 4.44 | |
| 26–30 | 36 (31.9) | 28.1 (1.4) | 9 | 25.0 | 27 | 29.7 | 1.02 | 0.31 | 1.64 | 0.63, 4.28 | |
| 31–35 | 31 (27.4) | 33.0 (1.4) | 4 | 12.9 | 27 | 29.7 | 0.67 | 0.41 | 0.53 | 0.16, 1.70 | |
| > 35 | 18 (15.9) | 39.3 (3.0) | 2 | 11.1 | 16 | 17.6 | 0.42 | 0.51 | 0.47 | 0.10, 2.21 | |
| Education | No formal | 5 (4.4) | 36.6 (6.9) | 2 | 4.0 | 3 | 3.3 | 0.37 | 0.54 | 2.9 | 0.46, 18.73 |
| Primary | 13 (11.5) | 33.5 (6.9) | 0 | 0.0 | 13 | 14.3 | 2.29 | 0.13 | 0.0 | Undefined | |
| Secondary | 51 (45.1) | 28.7 (59) | 12 | 23.5 | 39 | 42.9 | 0.97 | 0.32 | 1.6 | 0.63, 4.08 | |
| Tertiary | 44 (38.9) | 29.6 (4.3) | 8 | 18.2 | 36 | 39.6 | 0.08 | 0.78 | 0.87 | 0.33, 2.29 | |
| Occupation | House wives | 11 (9.7) | 25.8 (3.5) | 1 | 9.1 | 10 | 11.0 | 0.26 | 0.61 | 0.39 | 0.05, 3.18 |
| Labor work | 6 (5.3) | 30.7 (6.4) | 1 | 18.5 | 5 | 5.5 | 0.00 | 1.00 | 0.82 | 0.09, 7.39 | |
| Office work | 25 (22.1) | 32.3 (5.1) | 3 | 12.0 | 22 | 24.2 | 0.61 | 0.43 | 0.50 | 0.13, 1.83 | |
| Students | 17 (15.0) | 25.3 (4.0) | 5 | 29.4 | 12 | 13.2 | 1.25 | 0.26 | 1.93 | 0.60, 6.22 | |
| Traders | 54 (47.8) | 31.1 (5.8) | 12 | 22.2 | 42 | 46.1 | 0.50 | 0.48 | 1.40 | 0.55, 3.57 | |
| Trimester | First | 19 (16.8) | 28.6 (5.9) | 3 | 15.8 | 16 | 17.6 | 0.02 | 0.90 | 0.74 | 0.19, 2.80 |
| Second | 54 (47.8) | 30.2 (5.6) | 8 | 14.8 | 46 | 50.5 | 1.42 | 0.23 | 0.56 | 0.21, 1.46 | |
| Third | 40 (35.4) | 30.3 (6.1) | 11 | 27.5 | 29 | 31.9 | 2.52 | 0.11 | 2.14 | 0.83, 5.50 | |
| Gravidity | Primigravida | 32 (28.3) | 26.8 (5.2) | 8 | 25.0 | 24 | 26.5 | 0.86 | 0.35 | 1.60 | 0.60, 4.28 |
| Secundigravida | 32 (28.3) | 27.3 (3.7) | 4 | 12.5 | 28 | 30.8 | 0.83 | 0.36 | 0.50 | 0.15, 1.61 | |
| Multigravida | 49 (43.4) | 33.7 (5.1) | 10 | 20.4 | 39 | 42.9 | 0.05 | 0.83 | 1.11 | 0.44, 2.83 | |
| Anemia | None/Mild | 33 (29.2) | 30.3 (7.2) | 3 | 9.0 | 30 | 33.0 | 2.33* | 0.13 | 3.11 | 0.85, 11.36 |
| Moderate/ Severe | 80 (70.8) | 29.8 (5.2) | 19 | 23.8 | 61 | 67.0 | |||||
Fig. 1Treatment and prevention measures practiced amongst pregnant women participants attending Ikordu and Ijede General Hospitals in Lagos, Nigeria
Factors associated with peripheral parasitemia during malaria in pregnancy using univariate and multivariate analysis
| Variable | Peripheral parasitaemia % (Positive/total) | Univariate | Multivariate | ||
|---|---|---|---|---|---|
| Adjusted OR (95% CI) | P-value | Adjusted OR (95% CI) | P-value | ||
| 1st pregnancy | 25.0 (8/32) | 1.35 (0.52–2.49) | 0.006 | 1.22 (0.49–2.12) | 0.008 |
| 2nd or further pregnancies | 18.5 (15/81) | 1 | 1 | ||
| Age < 20 years | 25.0 (1/4) | 1.30 (0.14–12.20) | 0.052 | 1.24 (0.05–10.91) | 0.092 |
| Age ≥ 20 years | 19.3 (21/109) | 1 | 1 | ||
| LLIN use | 33.3 (5/15) | 1.92 (0.62–5.98) | 0.001 | 1.91 (0.56–587) | 0.007 |
| No LLIN use | 17.3 (17/98) | 1 | 1 | ||
| Anti-malarial use | 27.3 (15/55) | 2.3 (0.14–0.41) | 0.005 | 0.37 (0.24–0.55) | 0.031 |
| No anti-malarial use | 12.0 (7/58) | 1 | 1 | ||
| IPTp participation | 18.8 (6/32) | 0.95 (0.34–2.64) | 0.060 | 0.85 (0.41–2.26) | 0.025 |
| No IPTp participation | 19.8 (16/81) | 1 | 1 | ||
| Herb use | 18.2 (6/33) | 0.91 (0.33–2.53) | 0.026 | 0.94 (0.40–2.24) | 0.231 |
| No herb use | 20 (16/80) | 1 | 1 | ||
| Formal education | 17.6 (19/108) | 0.44 (0.34–10.50) | 0.005 | 0.64 (0.48–5.66) | 0.002 |
| No formal education | 40.0 (2/5) | 1 | 1 | ||
Fig. 2Malaria prevalence and parasitaemia (GMPD) according to the gravidity of pregnant women participants attending Ikordu and Ijede General Hospitals in Lagos, Nigeria
Fig. 3Malaria prevalence and geometric mean parasite density (GMPD) according to gestational ages of pregnant participants attending Ikordu and Ijede General Hospitals, in Lagos, Nigeria
Fig. 4Malaria prevalence and geometric mean parasite density (GMPD) according to age groups of pregnant women participants attending Ikordu and Ijede General Hospitals, in Lagos, Nigeria
Behavioural factors associated with anaemia during malaria in pregnancy using univariate
| Variable | Freq (%) | Anaemia | Mean (±sd) PCV | χ² | P-value | OR | 95% CI | t-test | P-value | |
|---|---|---|---|---|---|---|---|---|---|---|
| None/Mild | Moderate/Severe | |||||||||
| Parasitaemia | 22 (19.5) | 3 (14.3) | 19 (90.5) | 26.8 (6.6) | 2.33 | 0.13 | 3.11 | 0.85–11.36 | −2.60 | 0.007 |
| No parasitaemia | 91 (80.5) | 30 (32.6) | 61 (66.3) | 30.8 (6.0) | ||||||
| Education | ||||||||||
| None | 5 (4.4) | 1 (20.0) | 4 (80.0) | 29.6 (5.5) | 0.00 | 1.00 | 1.68 | 0.18–15.66 | – | – |
| Primary | 13 (11.5) | 1 (7.0) | 12 (92.3) | 28.9 (4.1) | 2.22 | 0.14 | 5.65 | 0.70–45.33 | 0.26 | 0.40 |
| Secondary | 51 (45.1) | 18 (35.3) | 33 (64.7) | 29.9 (6.2) | 1.67 | 0.20 | 0.58 | 0.26–1.32 | −0.12 | 0.46 |
| Tertiary | 44 (39.0) | 13 (29.6) | 31 (70.5) | 30.6 (7.0) | 0.004 | 0.95 | 0.97 | 0.42–2.23 | −0.37 | 0.36 |
| Pregnancy | ||||||||||
| 1st | 32 (28.3) | 11 (34.4) | 21 (65.7) | 29.6 (6.3) | 0.58 | 0.45 | 0.71 | 0.30–1.71 | −0.46 | 0.33 |
| > 1st | 81 (71.7) | 22 (27.1) | 59 (72.8) | 30.2 (6.3) | ||||||
| Trimester | ||||||||||
| First | 19 (16.8) | 5 (15.1) | 14 (17.5) | 30.9 (7.2) | 0.09 | 0.76 | 1.19 | 0.39, 3.61 | – | – |
| Second | 54 (47.8) | 15 (45.5) | 39 (48.7) | 29.5 (6.3) | 0.10 | 0.75 | 1.14 | 0.51, 2.57 | 0.75 | 0.23 |
| Third | 40 (35.4) | 13 (39.4) | 27 (33.8) | 30.4 (5.9) | 0.33 | 0.57 | 0.78 | 0.34, 1.81 | 0.26 | 0.60 |
| Age (years) | ||||||||||
| ≤ 20 | 4 (3.5) | 1 (25.0) | 3 (75.0) | 30.3 (5.4) | 0.00 | 1.00 | 1.25 | 0.12–12.44 | – | – |
| 21–25 | 24 (21.2) | 10 (41.7) | 14 (58.4) | 30.3 (7.4) | 2.29 | 0.13 | 0.49 | 0.19–1.25 | 0.0 | 1.00 |
| 26–30 | 36 (31.9) | 6 (16.7) | 30 (83.3) | 29.1 (5.1) | 4.02 | 0.04 | 2.70 | 1.00–7.29 | 0.42 | 0.35 |
| 31–35 | 31 (27.4) | 8 (25.8) | 23 (74.2) | 29.9 (7.1) | 0.24 | 0.62 | 1.26 | 0.50–3.20 | 0.13 | 0.45 |
| > 35 | 18 (159) | 8 (44.5) | 10 (55.6) | 31.9 (5.6) | 2.40 | 0.12 | 0.45 | 0.16–1.26 | −0.53 | 0.31 |
| ITN | ||||||||||
| Use | 15 (13.3) | 5 (33.3) | 10 (66.7) | 30.5 (6.5) | 0.14 | 0.71 | 0.80 | 0.25–2.55 | 0.28 | 0.39 |
| Non-use | 98 (86.7) | 28 (28.6) | 70 (71.4) | 30.0 (6.3) | ||||||
| Anti-malarial | ||||||||||
| Use | 55 (48.7) | 17 (30.9) | 38 (69.1) | 29.4 (6.2) | 0.15 | 0.70 | 0.85 | 0.38–1.92 | −1.01 | 0.16 |
| Non-use | 58 (51.3) | 16 (27.6) | 42 (72.4) | 30.6 (6.4) | ||||||
| IPTp | ||||||||||
| Use | 32 (28.3) | 12 (37.5) | 20 (62.5) | 30.3 (6.7) | 1.49 | 0.22 | 0.58 | 0.24–1.39 | 0.29 | 0.39 |
| Non-use | 81 (71.7) | 21 (25.9) | 60 (74.1) | 29.9 (6.1) | ||||||
| Herb | ||||||||||
| Use | 33 (29.2) | 7 (21.2) | 26 (78.8) | 28.2 (5.2) | 1.44 | 0.23 | 1.79 | 0.69–4.66 | −2.23 | 0.01 |
| Non-use | 80 (70.8) | 26 (32.5) | 54 (67.5) | 30.8 (6.6) | ||||||